logo
Plus   Neg
Share
Email

WuXi Biologics To Buy Bayer's Drug Product Plant In Germany

WuXi Biologics Germany GmbH will take over the operations of one of Bayer's final drug product manufacturing plants in Leverkusen, Germany, and purchase the associated equipment, in combination with a long-term lease contract for the building. Financial details were not disclosed.

The plant would be operated by WuXi Biologics and serve as a back-up site for the final product manufacturing of Kovaltry, an antihemophilic factor.

The transaction is expected to be concluded in the coming months subject to the satisfaction of customary closing conditions.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Arts and crafts chain Hobby Lobby has been ordered to shut its stores after the retailer reopened them by defying stay-at-home orders in various states amid the coronavirus pandemic. Ohio Attorney General Dave Yost said on Twitter that he sent a cease-and-desist letter following which the retailer agreed to close its stores on Wednesday night. Boston Scientific Corp. said Thursday that to lessen the impact of the coronavirus pandemic on its business, it will significantly reduce the salaries of its chief executive officer, directors and executive committee members. The company also intends to temporarily reduce work week schedules for employees, where appropriate. The medical device maker said these measures are to reduce costs. Marriott International announced a security data breach at its property system that hit up to approximately 5.2 million guests. The breached information is believed to exclude Marriott Bonvoy account passwords or PINs, payment card information, passport information, national IDs, or driver's license numbers. The latest incident, however, is less severe compared to the hotel chain's 2018 data breac
Follow RTT
>